Systemic delivery of adeno-associated viral vectors

This publication has 146 references indexed in Scilit:

• Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue
  Gene Therapy, 2012
• AAV6-mediated Systemic shRNA Delivery Reverses Disease in a Mouse Model of Facioscapulohumeral Muscular Dystrophy
  Molecular Therapy, 2011
• A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8
  Molecular Therapy, 2011
• Bovine AAV transcytosis inhibition by tannic acid results in functional expression of CFTR in vitro and altered biodistribution in vivo
  Gene Therapy, 2011
• AAV-microdystrophin Therapy Improves Cardiac Performance in Aged Female mdx Mice
  Molecular Therapy, 2011
• Efficacy of a Combined Intracerebral and Systemic Gene Delivery Approach for the Treatment of a Severe Lysosomal Storage Disorder
  Molecular Therapy, 2011
• Gene Therapy of mdx Mice With Large Truncated Dystrophins Generated by Recombination Using rAAV6
  Molecular Therapy, 2011
• Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution
  Gene Therapy, 2010
• Widespread Muscle Expression of an AAV9 Human Mini-dystrophin Vector After Intravenous Injection in Neonatal Dystrophin-deficient Dogs
  Molecular Therapy, 2010
• Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8
  Molecular Therapy, 2006